<?xml version="1.0" encoding="UTF-8"?>
<p>Based on this data, a prophylactic dose of low molecular weight heparin has been advised to hospitalized COVID-19 patients, despite abnormal coagulation tests, and the thrombotic risk associated with prolonged bed resting (
 <xref rid="B27" ref-type="bibr">27</xref>).
</p>
